Clinical trials recruiting for Acute Coronary Syndrome
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 30-day DAPT | 1 |
| Aspirin | 1 |
| Clopidogrel | 1 |
| Dabigatran Etexilate | 1 |
| Doxycycline | 1 |
| Guideline-directed therapy | 1 |
| Ticagrelor | 1 |
Self-screener
Recruiting trials
- Cardiology Research Dubrava Prospective Registry
- Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
- Feasibility Study of a Digital Interactive Life-style Platform for Individuals After Rehabilitation
- Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Heart Failure-USB: Prediction and Progression
- Impact of COVID19 Outbreak in Cardiac Acute Care
- Internet-based Behavioral Intervention Following ACS
- Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)
- What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Related conditions
Trials recruiting for Acute Coronary Syndrome often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Acute Coronary Syndrome trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.